1

2

3
Hiroyuki Setoi, Takehiko Ohkawa, Tatsuya Zenkoh, Hitoshi Sawada, Kentaro Sato, Hirokazu Tanaka: Benzamide derivatives and their use as vasopressin antagonists. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, April 25, 2000: US06054457 (25 worldwide citation)

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc, and represented by general formula (I): ##STR1## wherein R.sup.1 is aryl optionally substituted with lower alkoxy, etc., R.sup.2 is lower alkyl, etc.,


4
Hiroyuki Setoi, Takehiko Ohkawa, Tatsuya Zenkoh, Keiji Hemmi, Hirokazu Tanaka: Benzamide derivatives as vasopressin antagonists. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, April 3, 2001: US06211242 (19 worldwide citation)

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc. and represented by the general formula (I):


5
Setoi Hiroyuki, Ohkawa Takehiko, Zenkoh Tatsuya, Sawada Hitoshi, Sato Kentaro, Tanaka Hirokazu: Benzamide derivatives and their use as vasopressin antagonists. Fujisawa Pharmaceutical Co, April 1, 1998: EP0832061-A1 (1 worldwide citation)

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc., and represented by general formula (I), wherein R is aryl optionally substituted with lower alkoxy, etc., R is lower alkyl, etc., R is hydrogen, etc., R is lower alkoxy, etc., R is hydrogen, etc., A ...


6
Setoi Hiroyuki, Zenkoh Tatsuya, Sawada Hitoshi: Benzamide derivatives and their use as vasopressin antagonists. Fujisawa Pharmaceutical, liu yuanjin, September 9, 1998: CN96196175

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc, and represented by general formula (I), wherein R is aryl optionally substituted with lower alkoxy, etc, R is lower alkyl, etc, R is hydrogen, etc, R is lower alkoxy, etc, R is hydrogen, etc, A is NH ...


7
Setoi Hiroyuki, Ohkawa Takehiko, Osoda Kazuhiko: Benzamide derivatives. Fujisawa Pharmaceutical, Setoi Hiroyuki, Ohkawa Takehiko, Osoda Kazuhiko, TABUSHI Eiji, January 4, 2001: WO/2001/000618

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc. and represented by general formula (I): wherein R?1¿ and R?2¿ are taken together to form benzene ring, etc., R?3¿ is hydrogen, etc, R?4¿ and R?5¿ are each hydrogen, etc., R?6¿ and ?R7¿ are each hydro ...


8
Setoi Hiroyuki, Ohkawa Takehiko, Zenkoh Tatsuya, Hemmi Keiji, Tanaka Hirokazu: Benzamide derivatives as vasopressin antagonists. Fujisawa Pharmaceutical, Setoi Hiroyuki, Ohkawa Takehiko, Zenkoh Tatsuya, Hemmi Keiji, Tanaka Hirokazu, SEKI Hideo, November 2, 1995: WO/1995/029152

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc. and represented by general formula (I), wherein R?1¿ is aryl optionally substituted with lower alkyl, etc., R?2¿ is lower alkyl, etc., R?3¿ is hydrogen, etc., R?4¿ is aryl, etc., X is CH or N, and Y ...


9
Setoi Hiroyuki, Ohkawa Takehiko, Zenkoh Tatsuya, Sawada Hitoshi, Sato Kentaro, Tanaka Hirokazu: Benzamide derivatives and their use as vasopressin antagonists. Fujisawa Pharmaceutical, Setoi Hiroyuki, Ohkawa Takehiko, Zenkoh Tatsuya, Sawada Hitoshi, Sato Kentaro, Tanaka Hirokazu, SEKI Hideo, December 27, 1996: WO/1996/041795

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc., and represented by general formula (I), wherein R?1¿ is aryl optionally substituted with lower alkoxy, etc., R?2¿ is lower alkyl, etc., R?3¿ is hydrogen, etc., R?4¿ is lower alkoxy, etc., R?5¿ is hy ...


10
Setoi Hiroyuki, Ohkawa Takehiko, Zenkoh Tatsuya, Sawada Hitoshi, Sawada Yuki, Oku Teruo: Benzamide derivatives having a vasopressin antagonistic activity. Fujisawa Pharmaceutical, Setoi Hiroyuki, Ohkawa Takehiko, Zenkoh Tatsuya, Sawada Hitoshi, Sawada Yuki, Oku Teruo, SEKI Hideo, June 11, 1998: WO/1998/024771

This invention relates to new benzamide derivatives having a vasopressin antagonistic activity, etc. and represented by general formula (I) wherein R?1¿ is aryl optionally substituted with lower alkoxy, etc., R?2¿ is lower alkyl, etc., R?3¿ is hydrogen etc., A is NH, etc., E is (a), etc., X is -CH=C ...